International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA ; volume:18 ; number:1 ; day:9 ; month:8 ; year:2018 ; pages:1-11 ; date:12.2018
BMC cancer ; 18, Heft 1 (9.8.2018), 1-11, 12.2018
- Creator
-
Keppens, Cleo
Dequeker, Elisabeth M. C.
Patton, Simon J.
Normanno, Nicola
Fenizia, Francesca
Butler, Rachel
Cheetham, Melanie
Fairley, Jennifer A.
Williams, Hannah
Hall, Jacqueline A.
Schuuring, Ed
Deans, Zandra C.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-018-4694-x
- URN
-
urn:nbn:de:101:1-2019112718230781762897
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Keppens, Cleo
- Dequeker, Elisabeth M. C.
- Patton, Simon J.
- Normanno, Nicola
- Fenizia, Francesca
- Butler, Rachel
- Cheetham, Melanie
- Fairley, Jennifer A.
- Williams, Hannah
- Hall, Jacqueline A.
- Schuuring, Ed
- Deans, Zandra C.
- SpringerLink (Online service)
Other Objects (12)
Biomarkers in cancer/Circulating tumour markers
Circulating Tumour DNA in Melanoma—Clinic Ready?
Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
Ex vivo expansion of circulating tumour cells (CTCs)
Unravelling mutational signatures with plasma circulating tumour DNA
Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer
Enhanced BARM - Authentic Reporting to External Platforms
Cancer metastasis chemoprevention prevents circulating tumour cells from germination
Implementation of circulating tumour DNA multi-target mutation testing in plasma: a perspective from an external quality assessment providers’ survey
Two magnetic enrichment methods for pancreatic circulating tumour cells detection
Biomarkers in cancer/Circulating tumour markers
Circulating Tumour DNA in Melanoma—Clinic Ready?
Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
Ex vivo expansion of circulating tumour cells (CTCs)
Unravelling mutational signatures with plasma circulating tumour DNA
Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer
Enhanced BARM - Authentic Reporting to External Platforms
Cancer metastasis chemoprevention prevents circulating tumour cells from germination
Implementation of circulating tumour DNA multi-target mutation testing in plasma: a perspective from an external quality assessment providers’ survey
Two magnetic enrichment methods for pancreatic circulating tumour cells detection
Biomarkers in cancer/Circulating tumour markers
Circulating Tumour DNA in Melanoma—Clinic Ready?
Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
Ex vivo expansion of circulating tumour cells (CTCs)
Unravelling mutational signatures with plasma circulating tumour DNA
Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer
Enhanced BARM - Authentic Reporting to External Platforms
Cancer metastasis chemoprevention prevents circulating tumour cells from germination
Implementation of circulating tumour DNA multi-target mutation testing in plasma: a perspective from an external quality assessment providers’ survey